-
1
-
-
11144357696
-
Pharmacokinetics of a new autogel formulation of the somatostatin analogue lanreotide after a single subcutaneous dose in healthy volunteers
-
Antonijoan, R. M., Barbanoj, M. J., Cordero, J. A., Peraire, C., Obach, R., Vallès, J., et al. (2004). Pharmacokinetics of a new autogel formulation of the somatostatin analogue lanreotide after a single subcutaneous dose in healthy volunteers. Journal of Pharmacy and Pharmacology, 56(4), 471-476.
-
(2004)
Journal of Pharmacy and Pharmacology
, vol.56
, Issue.4
, pp. 471-476
-
-
Antonijoan, R.M.1
Barbanoj, M.J.2
Cordero, J.A.3
Peraire, C.4
Obach, R.5
Vallès, J.6
-
2
-
-
69749100391
-
ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Follow-up and documentation
-
Arnold, R., Chen, Y. J., Costa, F., Falconi, M., Gross, D., Grossman, A. B., et al. (2009). ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Follow-up and documentation. Neuroendocrinology, 90(2), 227-233.
-
(2009)
Neuroendocrinology
, vol.90
, Issue.2
, pp. 227-233
-
-
Arnold, R.1
Chen, Y.J.2
Costa, F.3
Falconi, M.4
Gross, D.5
Grossman, A.B.6
-
3
-
-
21044441388
-
Long-acting octreotide and prolonged-release lanreotide formulations have different pharmacokinetic profiles
-
Astruc, B., Marbach, P., Bouterfa, H., Denot, C., Safari, M., Vitaliti, A., et al. (2005). Long-acting octreotide and prolonged-release lanreotide formulations have different pharmacokinetic profiles. Journal of Clinical Pharmacology, 45(7), 836-844.
-
(2005)
Journal of Clinical Pharmacology
, vol.45
, Issue.7
, pp. 836-844
-
-
Astruc, B.1
Marbach, P.2
Bouterfa, H.3
Denot, C.4
Safari, M.5
Vitaliti, A.6
-
4
-
-
0030447911
-
Thyrotropin-secreting pituitary tumors
-
Beck-Peccoz, P., Brucker-Davis, F., Persani, L., Smallridge, R. C., & Weintraub, B. D. (1996). Thyrotropin-secreting pituitary tumors. Endocrine Reviews, 17(6), 610-638.
-
(1996)
Endocrine Reviews
, vol.17
, Issue.6
, pp. 610-638
-
-
Beck-Peccoz, P.1
Brucker-Davis, F.2
Persani, L.3
Smallridge, R.C.4
Weintraub, B.D.5
-
5
-
-
70449127649
-
Differential ligand-mediated pituitary somatostatin receptor subtype signaling: Implications for corticotroph tumor therapy
-
Ben-Shlomo, A., Schmid, H., Wawrowsky, K., Pichurin, O., Hubina, E., Chesnokova, V., et al. (2009). Differential ligand-mediated pituitary somatostatin receptor subtype signaling: Implications for corticotroph tumor therapy. Journal of Clinical Endocrinology and Metabolism, 94(11), 4342-4350.
-
(2009)
Journal of Clinical Endocrinology and Metabolism
, vol.94
, Issue.11
, pp. 4342-4350
-
-
Ben-Shlomo, A.1
Schmid, H.2
Wawrowsky, K.3
Pichurin, O.4
Hubina, E.5
Chesnokova, V.6
-
6
-
-
15944427116
-
The antitumoral effects of somatostatin analog therapy in acromegaly
-
Bevan, J. S. (2005). The antitumoral effects of somatostatin analog therapy in acromegaly. Journal of Clinical Endocrinology and Metabolism, 90(3), 1856-1863.
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.3
, pp. 1856-1863
-
-
Bevan, J.S.1
-
7
-
-
9844226192
-
Somatostatin receptor imaging in somatotroph and non functioning pituitary adenomas: Correlation with hormonal and visual responses to octreotide
-
(Oxford)
-
Borson-Chazot, F., Houzard, C., Ajzenberg, C., Nocaudie, M., Duet, M., Mundler, O., et al. (1997). Somatostatin receptor imaging in somatotroph and non functioning pituitary adenomas: Correlation with hormonal and visual responses to octreotide. Clinical Endocrinology (Oxford), 47(5), 589-598.
-
(1997)
Clinical Endocrinology
, vol.47
, Issue.5
, pp. 589-598
-
-
Borson-Chazot, F.1
Houzard, C.2
Ajzenberg, C.3
Nocaudie, M.4
Duet, M.5
Mundler, O.6
-
8
-
-
58149383820
-
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): A multicenter, phase II trial
-
Boscaro, M., Ludlam, W. H., Atkinson, B., Glusman, J. E., Petersenn, S., Reincke, M., et al. (2009). Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): A multicenter, phase II trial. Journal of Clinical Endocrinology and Metabolism, 94(1), 115-122.
-
(2009)
Journal of Clinical Endocrinology and Metabolism
, vol.94
, Issue.1
, pp. 115-122
-
-
Boscaro, M.1
Ludlam, W.H.2
Atkinson, B.3
Glusman, J.E.4
Petersenn, S.5
Reincke, M.6
-
9
-
-
17844372727
-
Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrothropin-secreting pituitary adenomas
-
Caron, P., Arlot, S., Bauters, C., Chanson, P., Kuhn, J. M., Pugeat, M., et al. (2001). Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrothropin-secreting pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 86(6), 2849-285.
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.6
, pp. 2849-3285
-
-
Caron, P.1
Arlot, S.2
Bauters, C.3
Chanson, P.4
Kuhn, J.M.5
Pugeat, M.6
-
10
-
-
0027376928
-
Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas: A follow-up of 52 patients
-
Chanson, P., Weintraub, B. D., & Harris, A. G. (1993). Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas: A follow-up of 52 patients. Annals of Internal Medicine, 119(3), 236-240.
-
(1993)
Annals of Internal Medicine
, vol.119
, Issue.3
, pp. 236-240
-
-
Chanson, P.1
Weintraub, B.D.2
Harris, A.G.3
-
11
-
-
70349900717
-
Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: A prospective study
-
Colao, A., Auriemma, R. S., Galdiero, M., Lombardi, G., & Pivonello, R. (2009b). Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: A prospective study. Journal of Clinical Endocrinology and Metabolism, 94(10), 3746-56.
-
(2009)
Journal of Clinical Endocrinology and Metabolism
, vol.94
, Issue.10
, pp. 3746-3756
-
-
Colao, A.1
Auriemma, R.S.2
Galdiero, M.3
Lombardi, G.4
Pivonello, R.5
-
12
-
-
67650317928
-
Significant tumour shrinkage after 12 months of lanreotide Autogel-120mg treatment given first-line in acromegaly
-
Colao, A., Auriemma, R. S., Rebora, A., Galdiero, M., Resmini, E., Minuto, F., et al. (2009a). Significant tumour shrinkage after 12 months of lanreotide Autogel-120mg treatment given first-line in acromegaly. Clinical Endocrinology (Oxford), 71(2), 237-45.
-
(2009)
Clinical Endocrinology (Oxford)
, vol.71
, Issue.2
, pp. 237-245
-
-
Colao, A.1
Auriemma, R.S.2
Rebora, A.3
Galdiero, M.4
Resmini, E.5
Minuto, F.6
-
13
-
-
68549122568
-
Glucose tolerance and somatostatin analog treatment in acromegaly: A 12-month study
-
Colao, A., Auriemma, R. S., Savastano, S., Galdiero, M., Grasso, L. F., Lombardi, G., et al. (2009c). Glucose tolerance and somatostatin analog treatment in acromegaly: A 12-month study. Journal of Clinical Endocrinology and Metabolism, 94(8), 2907-14.
-
(2009)
Journal of Clinical Endocrinology and Metabolism
, vol.94
, Issue.8
, pp. 2907-2914
-
-
Colao, A.1
Auriemma, R.S.2
Savastano, S.3
Galdiero, M.4
Grasso, L.F.5
Lombardi, G.6
-
14
-
-
0035040518
-
Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance
-
Colao, A., Cuocolo, A., Marzullo, P., Nicolai, E., Ferone, D., Della Morte, A. M., et al. (2001). Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. Journal of Clinical Endocrinology and Metabolism, 86(4), 1551-1557.
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.4
, pp. 1551-1557
-
-
Colao, A.1
Cuocolo, A.2
Marzullo, P.3
Nicolai, E.4
Ferone, D.5
Della Morte, A.M.6
-
15
-
-
58249115098
-
Medical therapy for clinically non-functioning pituitary adenomas
-
Colao, A., Di Somma, C., Pivonello, R., Faggiano, A., Lombardi, G., & Savastano, S. (2008b). Medical therapy for clinically non-functioning pituitary adenomas. Endocrine-Related Cancer, 15(4), 905-15.
-
(2008)
Endocrine-Related Cancer
, vol.15
, Issue.4
, pp. 905-915
-
-
Colao, A.1
Di Somma, C.2
Pivonello, R.3
Faggiano, A.4
Lombardi, G.5
Savastano, S.6
-
16
-
-
1442326975
-
Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
-
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004). Systemic complications of acromegaly: Epidemiology, pathogenesis, and management. Endocrine Reviews, 25(1), 102-152.
-
(2004)
Endocrine Reviews
, vol.25
, Issue.1
, pp. 102-152
-
-
Colao, A.1
Ferone, D.2
Marzullo, P.3
Lombardi, G.4
-
17
-
-
0037726793
-
Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas
-
Colao, A., Filippella, M., Di Somma, C., Manzi, S., Rota, F., Pivonello, R., et al. (2003). Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas. Endocrine, 20(3), 279-283.
-
(2003)
Endocrine
, vol.20
, Issue.3
, pp. 279-283
-
-
Colao, A.1
Filippella, M.2
Di Somma, C.3
Manzi, S.4
Rota, F.5
Pivonello, R.6
-
18
-
-
34249019847
-
Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours
-
Colao, A., Filippella, M., Pivonello, R., Di Somma, C., Faggiano, A., & Lombardi, G. (2007b). Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours. European Journal of Endocrinology, 156(Suppl. 1, 4), 57-63.
-
(2007)
European Journal of Endocrinology
, vol.156
, Issue.SUPPL. 14
, pp. 57-63
-
-
Colao, A.1
Filippella, M.2
Pivonello, R.3
Di Somma, C.4
Faggiano, A.5
Lombardi, G.6
-
19
-
-
0032586754
-
The pituitary uptake of (111)inDTPA-D-phe1-octreotide in the normal pituitary and in pituitary adenomas
-
Colao, A., Lastoria, S., Ferone, D., Varrella, P., Marzullo, P., Pivonello, R., et al. (1999). The pituitary uptake of (111)inDTPA-D-phe1-octreotide in the normal pituitary and in pituitary adenomas. Journal of Endocrinological Investigation, 22(3), 176-183.
-
(1999)
Journal of Endocrinological Investigation
, vol.22
, Issue.3
, pp. 176-183
-
-
Colao, A.1
Lastoria, S.2
Ferone, D.3
Varrella, P.4
Marzullo, P.5
Pivonello, R.6
-
20
-
-
0032585243
-
Growth hormone and prolactin excess
-
Colao, A., & Lombardi, G. (1998). Growth hormone and prolactin excess. Lancet, 352(9138), 1455-1461.
-
(1998)
Lancet
, vol.352
, Issue.9138
, pp. 1455-1461
-
-
Colao, A.1
Lombardi, G.2
-
21
-
-
33846952880
-
First-line therapy of acromegaly: A statement of the A.L.I.C.E. (acromegaly primary medical treatment learning and improvement with continuous medical education) study group
-
Colao, A., Martino, E., Cappabianca, P., Cozzi, R., Scanarini, M., & Ghigo, E., et al. (2006a). First-line therapy of acromegaly: A statement of the A.L.I.C.E. (acromegaly primary medical treatment learning and improvement with continuous medical education) study group. Journal of Endocrinological Investigation, 29(11), 1017-1020.
-
(2006)
Journal of Endocrinological Investigation
, vol.29
, Issue.11
, pp. 1017-1020
-
-
Colao, A.1
Martino, E.2
Cappabianca, P.3
Cozzi, R.4
Scanarini, M.5
Ghigo, E.6
-
22
-
-
33744954691
-
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: A prospective study in 99 patients
-
Colao, A., Pivonello, R., Auriemma, R. S., Briganti, F., Galdiero, M., Tortora, F., et al. (2006b). Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: A prospective study in 99 patients. Journal of Clinical Endocrinology and Metabolism, 91(6), 2112-2118.
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.6
, pp. 2112-2118
-
-
Colao, A.1
Pivonello, R.2
Auriemma, R.S.3
Briganti, F.4
Galdiero, M.5
Tortora, F.6
-
23
-
-
36549040940
-
Beneficial effect of dose escalation of octreotide-LAR as first-line therapy in patients with acromegaly
-
Colao, A., Pivonello, R., Auriemma, R. S., Galdiero, M., Savastano, S., & Lombardi, G. (2007a). Beneficial effect of dose escalation of octreotide-LAR as first-line therapy in patients with acromegaly. European Journal of Endocrinology, 157(5), 579-587.
-
(2007)
European Journal of Endocrinology
, vol.157
, Issue.5
, pp. 579-587
-
-
Colao, A.1
Pivonello, R.2
Auriemma, R.S.3
Galdiero, M.4
Savastano, S.5
Lombardi, G.6
-
24
-
-
47549113650
-
Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy
-
Colao, A., Pivonello, R., Galderisi, M., Cappabianca, P., Auriemma, R. S., Galdiero, M., et al. (2008a). Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy. Journal of Clinical Endocrinology and Metabolism, 93(7), 2639-46.
-
(2008)
Journal of Clinical Endocrinology and Metabolism
, vol.93
, Issue.7
, pp. 2639-2646
-
-
Colao, A.1
Pivonello, R.2
Galderisi, M.3
Cappabianca, P.4
Auriemma, R.S.5
Galdiero, M.6
-
25
-
-
0023217385
-
Response of thyrothropin-secreting pituitary adenomas to a long acting somatostatin analogue
-
Comi, R. J., Gesunheit, N., Murray, L., Gorden, P., & Weintraub, B. D. (1987). Response of thyrothropin-secreting pituitary adenomas to a long acting somatostatin analogue. The New England Journal of Medicine, 317(1), 12-17.
-
(1987)
The New England Journal of Medicine
, vol.317
, Issue.1
, pp. 12-17
-
-
Comi, R.J.1
Gesunheit, N.2
Murray, L.3
Gorden, P.4
Weintraub, B.D.5
-
26
-
-
33646022576
-
Primary treatment of acromegaly with octreotide LAR: A long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage
-
Cozzi, R., Montini, M., Attanasio, R., Albizzi, M., Lasio, G., Lodrini, S., et al. (2006). Primary treatment of acromegaly with octreotide LAR: A long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage. Journal of Clinical Endocrinology and Metabolism, 91(4), 1397-1403.
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.4
, pp. 1397-1403
-
-
Cozzi, R.1
Montini, M.2
Attanasio, R.3
Albizzi, M.4
Lasio, G.5
Lodrini, S.6
-
27
-
-
0026485390
-
Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro
-
De Bruin, T. W., Kwekkeboom, D. J., van't Verlaat, J. W., Reubi, J. C., Krenning, E. P., Lamberts, S. W., et al. (1992). Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro. Journal of Clinical Endocrinology and Metabolism, 75(5), 1310-1317.
-
(1992)
Journal of Clinical Endocrinology and Metabolism
, vol.75
, Issue.5
, pp. 1310-1317
-
-
De Bruin, T.W.1
Kwekkeboom, D.J.2
van't Verlaat, J.W.3
Reubi, J.C.4
Krenning, E.P.5
Lamberts, S.W.6
-
28
-
-
0030667438
-
High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumours: Clinical and biological effects
-
Eriksson, B., Renstrup, J., Imam, H., & Oberg, K. (1997). High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumours: Clinical and biological effects. Annals of Oncology, 8(10), 1041-1044.
-
(1997)
Annals of Oncology
, vol.8
, Issue.10
, pp. 1041-1044
-
-
Eriksson, B.1
Renstrup, J.2
Imam, H.3
Oberg, K.4
-
29
-
-
54049152471
-
Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients
-
(Oxford)
-
Faggiano, A., Tavares, L. B., Tauchmanova, L., Milone, F., Mansueto, G., Ramundo, V., et al. (2008). Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients. Clinical Endocrinology (Oxford), 69(5), 756-762.
-
(2008)
Clinical Endocrinology
, vol.69
, Issue.5
, pp. 756-762
-
-
Faggiano, A.1
Tavares, L.B.2
Tauchmanova, L.3
Milone, F.4
Mansueto, G.5
Ramundo, V.6
-
30
-
-
43149098539
-
The biological characterization of neuroendocrine tumors: The role of neuroendocrine markers
-
Ferolla, P., Faggiano, A., Mansueto, G., Avenia, N., Cantelmi, M. G., Giovenali, P., et al. (2008). The biological characterization of neuroendocrine tumors: The role of neuroendocrine markers. Journal of Endocrinological Investigation, 31(3), 277-286.
-
(2008)
Journal of Endocrinological Investigation
, vol.31
, Issue.3
, pp. 277-286
-
-
Ferolla, P.1
Faggiano, A.2
Mansueto, G.3
Avenia, N.4
Cantelmi, M.G.5
Giovenali, P.6
-
31
-
-
33644664300
-
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation
-
Ferone, D., Arvigo, M., Semino, C., Jaquet, P., Saveanu, A., Taylor, J. E., et al. (2005). Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation. American Journal of Physiology, Endocrinology and Metabolism, 289(6), E1044-E1050.
-
(2005)
American Journal of Physiology, Endocrinology and Metabolism
, vol.289
, Issue.6
-
-
Ferone, D.1
Arvigo, M.2
Semino, C.3
Jaquet, P.4
Saveanu, A.5
Taylor, J.E.6
-
32
-
-
67649304857
-
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology
-
Epub
-
Ferone, D., Gatto, F., Arvigo, M., Resmini, E., Boschetti, M., Teti, C., et al. (2009). The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology. Journal of Molecular Endocrinology, 42(5), 361-370, Epub.
-
(2009)
Journal of Molecular Endocrinology
, vol.42
, Issue.5
, pp. 361-370
-
-
Ferone, D.1
Gatto, F.2
Arvigo, M.3
Resmini, E.4
Boschetti, M.5
Teti, C.6
-
34
-
-
23844540615
-
Long-acting somatostatin analog therapy of acromegaly: A meta-analysis
-
Freda, P. U., Katznelson, L., van der Lely, A. J., Reyes, C. M., Zhao, S., & Rabinowitz, D. (2005). Long-acting somatostatin analog therapy of acromegaly: A meta-analysis. Journal of Clinical Endocrinology and Metabolism, 90(8), 4465-4473.
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.8
, pp. 4465-4473
-
-
Freda, P.U.1
Katznelson, L.2
van der Lely, A.J.3
Reyes, C.M.4
Zhao, S.5
Rabinowitz, D.6
-
35
-
-
0032470088
-
Thyrotropin secreting pituitary adenoma effectively treated with octreotide
-
Fukuda, T., Yokoyama, N., Tamai, M., Imaizumi, M., Kimura, H., Tominaga, T., et al. (1998). Thyrotropin secreting pituitary adenoma effectively treated with octreotide. Internal Medicine, 37(12), 1027-1030.
-
(1998)
Internal Medicine
, vol.37
, Issue.12
, pp. 1027-1030
-
-
Fukuda, T.1
Yokoyama, N.2
Tamai, M.3
Imaizumi, M.4
Kimura, H.5
Tominaga, T.6
-
36
-
-
0027301770
-
Octreotide treatment does not affect the size of most non-functioning pituitary adenomas
-
Gasperi, M., Petrini, L., Pilosu, R., Nardi, M., Marcello, A. A., Mastio, F., et al. (1993). Octreotide treatment does not affect the size of most non-functioning pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 16(7), 541-543.
-
(1993)
Journal of Clinical Endocrinology and Metabolism
, vol.16
, Issue.7
, pp. 541-543
-
-
Gasperi, M.1
Petrini, L.2
Pilosu, R.3
Nardi, M.4
Marcello, A.A.5
Mastio, F.6
-
37
-
-
0030911816
-
Octreotide long-acting release (LAR) A review of its pharmacological properties and therapeutic use in the management of acromegaly
-
Gillis, J. C., Noble, S., & Goa, K. L. (1997). Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly. Drugs, 53(4), 681-699.
-
(1997)
Drugs
, vol.53
, Issue.4
, pp. 681-699
-
-
Gillis, J.C.1
Noble, S.2
Goa, K.L.3
-
38
-
-
68349141978
-
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy:Arandomised controlled trial
-
Giustina, A., Bonadonna, S., Bulgari, G., Colao, A., Cozzi, R., Cannavò, S., et al. (2009). High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy:Arandomised controlled trial. European Journal of Endocrinology, 161(2), 331-338.
-
(2009)
European Journal of Endocrinology
, vol.161
, Issue.2
, pp. 331-338
-
-
Giustina, A.1
Bonadonna, S.2
Bulgari, G.3
Colao, A.4
Cozzi, R.5
Cannavò, S.6
-
39
-
-
43749108350
-
The role of somatostatin analogues in the treatment of neuroendocrine tumours
-
Grozinsky-Glasberg, S., Grossman, A. B., & Korbonits, M. (2008). The role of somatostatin analogues in the treatment of neuroendocrine tumours. Molecular and Cellular Endocrinology, 286(1-2), 238-250.
-
(2008)
Molecular and Cellular Endocrinology
, vol.286
, Issue.1-2
, pp. 238-250
-
-
Grozinsky-Glasberg, S.1
Grossman, A.B.2
Korbonits, M.3
-
40
-
-
4043060884
-
Somatostatin receptors in pituitary function, diagnosis and therapy
-
Hofland, L. J., & Lamberts, S. W. (2004). Somatostatin receptors in pituitary function, diagnosis and therapy. Frontiers of Hormone Research, 32, 235-52.
-
(2004)
Frontiers of Hormone Research
, vol.32
, pp. 235-252
-
-
Hofland, L.J.1
Lamberts, S.W.2
-
41
-
-
20244376493
-
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
-
Hofland, L. J., van der Hoek, J., Feelders, R., van Aken, M. O., van Koetsveld, P. M., Waaijers, M., et al. (2005). The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5. European Journal of Endocrinology, 152(4), 645-654.
-
(2005)
European Journal of Endocrinology
, vol.152
, Issue.4
, pp. 645-654
-
-
Hofland, L.J.1
van der Hoek, J.2
Feelders, R.3
van Aken, M.O.4
van Koetsveld, P.M.5
Waaijers, M.6
-
42
-
-
23244442834
-
Treatment of acromegaly with octreotide-LAR: Extensive experience in a Brazilian institution
-
Jallad, R. S., Musolino, N. R., Salgado, L. R., & Bronstein,. D. (2005). Treatment of acromegaly with octreotide-LAR: Extensive experience in a Brazilian institution. Clinical Endocrinology (Oxford), 63(2), 168-175.
-
(2005)
Clinical Endocrinology (Oxford)
, vol.63
, Issue.2
, pp. 168-175
-
-
Jallad, R.S.1
Musolino, N.R.2
Salgado, L.R.3
Bronstein, D.4
-
43
-
-
2942675021
-
The diagnosis and medical management of advanced neuroendocrine tumors
-
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004). The diagnosis and medical management of advanced neuroendocrine tumors. Endocrine Reviews, 25(3), 458-511.
-
(2004)
Endocrine Reviews
, vol.25
, Issue.3
, pp. 458-511
-
-
Kaltsas, G.A.1
Besser, G.M.2
Grossman, A.B.3
-
44
-
-
0026440716
-
Chronic somatostatin analog administration in patients with a-subunit-secreting pituitary tumors
-
Katznelson, L., Oppenheim, D. S., Coughlin, J. F., Kliman, B., Schoenfeld, D. A., & Klibanski, A. (1992). Chronic somatostatin analog administration in patients with a-subunit-secreting pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 75(5), 1318-1325.
-
(1992)
Journal of Clinical Endocrinology and Metabolism
, vol.75
, Issue.5
, pp. 1318-1325
-
-
Katznelson, L.1
Oppenheim, D.S.2
Coughlin, J.F.3
Kliman, B.4
Schoenfeld, D.A.5
Klibanski, A.6
-
45
-
-
50249160709
-
Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines
-
Kidd, M., Drozdov, I., Joseph, R., Pfragner, R., Culler, M., & Modlin, I. (2008). Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines. Cancer, 113(4), 690-700.
-
(2008)
Cancer
, vol.113
, Issue.4
, pp. 690-700
-
-
Kidd, M.1
Drozdov, I.2
Joseph, R.3
Pfragner, R.4
Culler, M.5
Modlin, I.6
-
46
-
-
34547692987
-
A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation
-
Kidd, M., Modlin, I. M., Black, J. W., Boyce, M., & Culler, M. (2007). A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation. Regulatory Peptides, 143(1-3), 109-117.
-
(2007)
Regulatory Peptides
, vol.143
, Issue.1-3
, pp. 109-117
-
-
Kidd, M.1
Modlin, I.M.2
Black, J.W.3
Boyce, M.4
Culler, M.5
-
47
-
-
17744377962
-
Evaluation of the treatment of thyrothropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide
-
Kuhn, J. M.,Arlot, S., Lefebvre,H., Caron, P., Cortell-Rudelli, C., Archambaud, F., et al. (2000). Evaluation of the treatment of thyrothropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. Journal of Clinical Endocrinology and Metabolism, 85(4), 1487-149.
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, Issue.4
, pp. 1487-2149
-
-
Kuhn, J.M.1
Arlot, S.2
Lefebvre, H.3
Caron, P.4
Cortell-Rudelli, C.5
Archambaud, F.6
-
48
-
-
77449132297
-
Somatostatin receptor based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
-
[Epub ahead of print]
-
Kwekkeboom, D., Kam, B., Van Essen, M., Teunissen, J., Van Eijck, C., Valkema, R., et al. (2009). Somatostatin receptor based imaging and therapy of gastroenteropancreatic neuroendocrine tumors. Endocrine-Related Cancer. December 8 [Epub ahead of print].
-
(2009)
Endocrine-Related Cancer. December 8.
-
-
Kwekkeboom, D.1
Kam, B.2
Van Essen, M.3
Teunissen, J.4
Van Eijck, C.5
Valkema, R.6
-
49
-
-
0028788593
-
Imaging and medical management of clinically nonfunctioning pituitary tumours
-
Lamberts, S. W.J., de Herder, W. W., van der Lely, A. J., & Hofland, L. J. (1995). Imaging and medical management of clinically nonfunctioning pituitary tumours. Endocrinologist, 5, 448-451.
-
(1995)
Endocrinologist
, vol.5
, pp. 448-451
-
-
Lamberts, S.W.J.1
de Herder, W.W.2
van der Lely, A.J.3
Hofland, L.J.4
-
50
-
-
0030054029
-
Octreotide
-
Lamberts, S. W., van der Lely, A. J., de Herder, W. W., & Hofland, L. J. (1996). Octreotide. The New England Journal of Medicine, 334(4), 246-254.
-
(1996)
The New England Journal of Medicine
, vol.334
, Issue.4
, pp. 246-254
-
-
Lamberts, S.W.1
van der Lely, A.J.2
de Herder, W.W.3
Hofland, L.J.4
-
51
-
-
34249011944
-
Is there a real medical treatment for the 'non-secreting' pituitary adenomas? (abstract)
-
Liuzzi, A., Dallabonzana, D., & Oppizzi, G. (1991). Is there a real medical treatment for the 'non-secreting' pituitary adenomas? (abstract). Journal of Endocrinological Investigation, 14(Suppl. 1), 18.
-
(1991)
Journal of Endocrinological Investigation
, vol.14
, Issue.SUPPL. 1
, pp. 18
-
-
Liuzzi, A.1
Dallabonzana, D.2
Oppizzi, G.3
-
52
-
-
84884491303
-
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: A systematic review
-
[Epub ahead of print]
-
Mazziotti, G., & Giustina, A. (2009). Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: A systematic review. Pituitary. February 3 [Epub ahead of print].
-
(2009)
Pituitary. February 3.
-
-
Mazziotti, G.1
Giustina, A.2
-
53
-
-
70449366466
-
Acromegaly pathogenesis and treatment
-
Melmed, S. (2009). Acromegaly pathogenesis and treatment. The Journal of Clinical Investigation, 119(11), 3189-3202.
-
(2009)
The Journal of Clinical Investigation
, vol.119
, Issue.11
, pp. 3189-3202
-
-
Melmed, S.1
-
54
-
-
18544363593
-
Guidelines for acromegaly management
-
Melmed, S., Casanueva, F. F., Cavagnini, F., Chanson, P., Frohman, L., Grossman, A., et al. (2002). Guidelines for acromegaly management. Journal of Clinical Endocrinology and Metabolism, 87(9), 4054-4058.
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.9
, pp. 4054-4058
-
-
Melmed, S.1
Casanueva, F.F.2
Cavagnini, F.3
Chanson, P.4
Frohman, L.5
Grossman, A.6
-
55
-
-
34347380169
-
A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly
-
Mercado, M., Borges, F., Bouterfa, H., Chang, T. C., Chervin, A., Farrall, A. J., et al. (2007). A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly. Clinical Endocrinology (Oxford), 66(6), 859-868.
-
(2007)
Clinical Endocrinology (Oxford)
, vol.66
, Issue.6
, pp. 859-868
-
-
Mercado, M.1
Borges, F.2
Bouterfa, H.3
Chang, T.C.4
Chervin, A.5
Farrall, A.J.6
-
56
-
-
0027771501
-
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas
-
Merola, B., Colao, A., Ferone, D., Selleri, A., Di Sarno, A., Marzullo, P., et al. (1993). Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. Hormone Research, 40(4), 149-155.
-
(1993)
Hormone Research
, vol.40
, Issue.4
, pp. 149-155
-
-
Merola, B.1
Colao, A.2
Ferone, D.3
Selleri, A.4
Di Sarno, A.5
Marzullo, P.6
-
57
-
-
37449029464
-
Gastroenteropancreatic neuroendocrine tumours
-
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., et al. (2008). Gastroenteropancreatic neuroendocrine tumours. The Lancet Oncology, 9(1), 61-72.
-
(2008)
The Lancet Oncology
, vol.9
, Issue.1
, pp. 61-72
-
-
Modlin, I.M.1
Oberg, K.2
Chung, D.C.3
Jensen, R.T.4
de Herder, W.W.5
Thakker, R.V.6
-
58
-
-
49249113074
-
A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly
-
Murray, R. D., & Melmed, S. (2008). A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. Journal of Clinical Endocrinology and Metabolism, 93(8), 2957-2968.
-
(2008)
Journal of Clinical Endocrinology and Metabolism
, vol.93
, Issue.8
, pp. 2957-2968
-
-
Murray, R.D.1
Melmed, S.2
-
59
-
-
29244462313
-
Evaluation and treatment of Cushing's syndrome
-
Nieman, L. K., & Ilias, I. (2005). Evaluation and treatment of Cushing's syndrome. American Journal of Medicine, 118(12), 1340-1346.
-
(2005)
American Journal of Medicine
, vol.118
, Issue.12
, pp. 1340-1346
-
-
Nieman, L.K.1
Ilias, I.2
-
60
-
-
68149168844
-
Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors
-
Oberg, K. (2009). Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors. Expert Reviews Anticancer Therapy, 9(5), 557-566.
-
(2009)
Expert Reviews Anticancer Therapy
, vol.9
, Issue.5
, pp. 557-566
-
-
Oberg, K.1
-
61
-
-
34547756475
-
Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727
-
Ono, K., Suzuki, T., Miki, Y., Taniyama, Y., Nakamura, Y., Noda, Y., et al. (2007). Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727. Anticancer Research, 27(4B), 2231-2239.
-
(2007)
Anticancer Research
, vol.27
, Issue.4 B
, pp. 2231-2239
-
-
Ono, K.1
Suzuki, T.2
Miki, Y.3
Taniyama, Y.4
Nakamura, Y.5
Noda, Y.6
-
62
-
-
45749096710
-
Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells
-
Pasquali, D., Rossi, V., Conzo, G., Pannone, G., Bufo, P., De Bellis, A., et al. (2008). Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells. Journal of Molecular Endocrinology, 40(6), 263-271.
-
(2008)
Journal of Molecular Endocrinology
, vol.40
, Issue.6
, pp. 263-271
-
-
Pasquali, D.1
Rossi, V.2
Conzo, G.3
Pannone, G.4
Bufo, P.5
De Bellis, A.6
-
63
-
-
38349144642
-
Cushing's syndrome
-
Pivonello, R., De Martino, M. C., De Leo, M., Lombardi, G., & Colao, A. (2008). Cushing's syndrome. Endocrinology and Metabolism Clinics of North America, 37(1), 135-149.
-
(2008)
Endocrinology and Metabolism Clinics of North America
, vol.37
, Issue.1
, pp. 135-149
-
-
Pivonello, R.1
De Martino, M.C.2
De Leo, M.3
Lombardi, G.4
Colao, A.5
-
64
-
-
1942440916
-
Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: Comparison with the effectiveness of cabergoline treatment
-
Pivonello, R., Matrone, C., Filippella, M., Cavallo, L. M., Di Somma, C., Cappabianca, P., et al. (2004). Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: Comparison with the effectiveness of cabergoline treatment. Journal of Clinical Endocrinology and Metabolism, 89(4), 1674-1683.
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.4
, pp. 1674-1683
-
-
Pivonello, R.1
Matrone, C.2
Filippella, M.3
Cavallo, L.M.4
Di Somma, C.5
Cappabianca, P.6
-
65
-
-
0028135581
-
Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: Effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy
-
Plöckinger, U., Reichel, M., Fett, U., Saeger, W., & Quabbe, H. J. (1994). Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: Effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy. Journal of Clinical Endocrinology and Metabolism, 79(5), 1416-1423.
-
(1994)
Journal of Clinical Endocrinology and Metabolism
, vol.79
, Issue.5
, pp. 1416-1423
-
-
Plöckinger, U.1
Reichel, M.2
Fett, U.3
Saeger, W.4
Quabbe, H.J.5
-
66
-
-
0023118350
-
Secretion of somatostatin and its physiologic function
-
Reichlin, S. (1987). Secretion of somatostatin and its physiologic function. Journal of Laboratory and Clinical Medicine, 109(3), 320-326.
-
(1987)
Journal of Laboratory and Clinical Medicine
, vol.109
, Issue.3
, pp. 320-326
-
-
Reichlin, S.1
-
67
-
-
70350442637
-
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID study group
-
Rinke, A., Müller, H. H., Schade-Brittinger, C., Klose, K. J., Barth, P., Wied, M., et al. (2009). Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID study group. Journal of Clinical Oncology, 27(28), 4635-4636.
-
(2009)
Journal of Clinical Oncology
, vol.27
, Issue.28
, pp. 4635-4636
-
-
Rinke, A.1
Müller, H.H.2
Schade-Brittinger, C.3
Klose, K.J.4
Barth, P.5
Wied, M.6
-
68
-
-
0034616021
-
Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
-
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000). Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity. Science, 288(5463), 154-157.
-
(2000)
Science
, vol.288
, Issue.5463
, pp. 154-157
-
-
Rocheville, M.1
Lange, D.C.2
Kumar, U.3
Patel, S.C.4
Patel, R.C.5
Patel, Y.C.6
-
69
-
-
68649087646
-
Therapeutic options in the management of acromegaly: Focus on lanreotide autogel
-
Roelfsema, F., Biermasz, N. R., Pereira, A. M., & Romijn, J. A. (2008). Therapeutic options in the management of acromegaly: Focus on lanreotide autogel. Biologics, 2(3), 463-479.
-
(2008)
Biologics
, vol.2
, Issue.3
, pp. 463-479
-
-
Roelfsema, F.1
Biermasz, N.R.2
Pereira, A.M.3
Romijn, J.A.4
-
70
-
-
43549111835
-
Pasireotide (SOM230): Development, mechanism of action and potential applications
-
Schmid, H. A. (2008). Pasireotide (SOM230): Development, mechanism of action and potential applications. Molecular and Cellular Endocrinology, 286(1-2), 69-74.
-
(2008)
Molecular and Cellular Endocrinology
, vol.286
, Issue.1-2
, pp. 69-74
-
-
Schmid, H.A.1
-
71
-
-
0003343219
-
Histological typing of endocrine tumours
-
(2nd ed.) Berlin, Heidelberg NY Springer- Verlag
-
Solcia, E., Klöppel, G., & Sobin, L. H. (2000). Histological typing of endocrine tumours. World Health Organization international histological classification of tumours (2nd ed.). Berlin, Heidelberg, NY: Springer-Verlag.
-
(2000)
World Health Organization international histological classification of tumours
-
-
Solcia, E.1
Klöppel, G.2
Sobin, L.H.3
-
72
-
-
67349158003
-
Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapies
-
Srirajaskanthan, R., Watkins, J., Marelli, L., Khan, K., & Caplin, M. E. (2009). Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapies. Neuroendocrinology, 89 (3), 308-314.
-
(2009)
Neuroendocrinology
, vol.89
, Issue.3
, pp. 308-314
-
-
Srirajaskanthan, R.1
Watkins, J.2
Marelli, L.3
Khan, K.4
Caplin, M.E.5
-
73
-
-
0026424156
-
Analgesic effect on headaches of octreotide, a somatostatin analogue, in a case of non-functioning pituitary adenoma
-
Turpin, G., Foubert, L., Noel-Wekstein, S., Kujas, M., & De Gennes, J. L. (1991). Analgesic effect on headaches of octreotide, a somatostatin analogue, in a case of non-functioning pituitary adenoma. Presse Medicale, 20(43), 2219-2220.
-
(1991)
Presse Medicale
, vol.20
, Issue.43
, pp. 2219-2220
-
-
Turpin, G.1
Foubert, L.2
Noel-Wekstein, S.3
Kujas, M.4
De Gennes, J.L.5
-
74
-
-
0030820137
-
A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas: French multicenter octreotide study group
-
Warnet, A., Harris, A. G., Renard, E., Martin, D., James-Deidier, A., & Chaumet-Riffaud, P. (1997). A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas: French multicenter octreotide study group. Neurosurgery, 41(4), 786-797.
-
(1997)
Neurosurgery
, vol.41
, Issue.4
, pp. 786-797
-
-
Warnet, A.1
Harris, A.G.2
Renard, E.3
Martin, D.4
James-Deidier, A.5
Chaumet-Riffaud, P.6
-
75
-
-
0024398022
-
The effect of somatostatin analogue on chiasmal dysfunction from pituitary macroadenomas
-
Warnet, A., Timsit, J., Chanson, P., Guillausseau, P. J., Zamfirescu, F., Harris, A. G., et al. (1989). The effect of somatostatin analogue on chiasmal dysfunction from pituitary macroadenomas. Journal of Neurosurgery, 71(5), 687-690.
-
(1989)
Journal of Neurosurgery
, vol.71
, Issue.5
, pp. 687-690
-
-
Warnet, A.1
Timsit, J.2
Chanson, P.3
Guillausseau, P.J.4
Zamfirescu, F.5
Harris, A.G.6
-
76
-
-
46449110634
-
One hundred years after "carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
-
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., et al. (2008). One hundred years after "carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of Clinical Oncology, 26(18), 3063-3072.
-
(2008)
Journal of Clinical Oncology
, vol.26
, Issue.18
, pp. 3063-3072
-
-
Yao, J.C.1
Hassan, M.2
Phan, A.3
Dagohoy, C.4
Leary, C.5
Mares, J.E.6
|